Last reviewed · How we verify
Glucocorticosteroid injection
At a glance
| Generic name | Glucocorticosteroid injection |
|---|---|
| Also known as | Methylprednisolone, Depo-medrol |
| Sponsor | Bispebjerg Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (PHASE1)
- A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (PHASE3)
- A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
- Achilles Tendinopathy Treated With Training and Injections (PHASE4)
- Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis (PHASE1)
- Plantar Fasciitis, Operation or Conservative Treatment (PHASE4)
- Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof. (PHASE4)
- Exercise Therapy and Ultrasound Guided Injections in Painful Shoulder (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |